207 related articles for article (PubMed ID: 18549881)
21. Rapid and reliable generation of invariant natural killer T-cell lines in vitro.
Chiba A; Cohen N; Brigl M; Brennan PJ; Besra GS; Brenner MB
Immunology; 2009 Nov; 128(3):324-33. PubMed ID: 20067532
[TBL] [Abstract][Full Text] [Related]
22. Pathogen-expanded CD11b+ invariant NKT cells feedback inhibit T cell proliferation via membrane-bound TGF-β1.
Han Y; Jiang Z; Chen Z; Gu Y; Liu Y; Zhang X; Cao X
J Autoimmun; 2015 Apr; 58():21-35. PubMed ID: 25592391
[TBL] [Abstract][Full Text] [Related]
23. Invariant NKT cells exacerbate type 1 diabetes induced by CD8 T cells.
Griseri T; Beaudoin L; Novak J; Mars LT; Lepault F; Liblau R; Lehuen A
J Immunol; 2005 Aug; 175(4):2091-101. PubMed ID: 16081775
[TBL] [Abstract][Full Text] [Related]
24. Type II Natural Killer T Cells Contribute to Protection Against Systemic Methicillin-Resistant
Genardi S; Visvabharathy L; Cao L; Morgun E; Cui Y; Qi C; Chen YH; Gapin L; Berdyshev E; Wang CR
Front Immunol; 2020; 11():610010. PubMed ID: 33312179
[TBL] [Abstract][Full Text] [Related]
25. The presence of CD8+ invariant NKT cells in mice.
Lee H; Hong C; Shin J; Oh S; Jung S; Park YK; Hong S; Lee GR; Park SH
Exp Mol Med; 2009 Dec; 41(12):866-72. PubMed ID: 19745607
[TBL] [Abstract][Full Text] [Related]
26. The length of lipids bound to human CD1d molecules modulates the affinity of NKT cell TCR and the threshold of NKT cell activation.
McCarthy C; Shepherd D; Fleire S; Stronge VS; Koch M; Illarionov PA; Bossi G; Salio M; Denkberg G; Reddington F; Tarlton A; Reddy BG; Schmidt RR; Reiter Y; Griffiths GM; van der Merwe PA; Besra GS; Jones EY; Batista FD; Cerundolo V
J Exp Med; 2007 May; 204(5):1131-44. PubMed ID: 17485514
[TBL] [Abstract][Full Text] [Related]
27. Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy.
Silk JD; Hermans IF; Gileadi U; Chong TW; Shepherd D; Salio M; Mathew B; Schmidt RR; Lunt SJ; Williams KJ; Stratford IJ; Harris AL; Cerundolo V
J Clin Invest; 2004 Dec; 114(12):1800-11. PubMed ID: 15599405
[TBL] [Abstract][Full Text] [Related]
28. Invariant NKT cells sustain specific B cell responses and memory.
Galli G; Pittoni P; Tonti E; Malzone C; Uematsu Y; Tortoli M; Maione D; Volpini G; Finco O; Nuti S; Tavarini S; Dellabona P; Rappuoli R; Casorati G; Abrignani S
Proc Natl Acad Sci U S A; 2007 Mar; 104(10):3984-9. PubMed ID: 17360464
[TBL] [Abstract][Full Text] [Related]
29. Expansion and hyperactivity of CD1d-restricted NKT cells during the progression of systemic lupus erythematosus in (New Zealand Black x New Zealand White)F1 mice.
Forestier C; Molano A; Im JS; Dutronc Y; Diamond B; Davidson A; Illarionov PA; Besra GS; Porcelli SA
J Immunol; 2005 Jul; 175(2):763-70. PubMed ID: 16002672
[TBL] [Abstract][Full Text] [Related]
30. The CD1d-binding glycolipid alpha-galactosylceramide enhances humoral immunity to T-dependent and T-independent antigen in a CD1d-dependent manner.
Lang GA; Exley MA; Lang ML
Immunology; 2006 Sep; 119(1):116-25. PubMed ID: 16792697
[TBL] [Abstract][Full Text] [Related]
31. Human invariant NKT cells display alloreactivity instructed by invariant TCR-CD1d interaction and killer Ig receptors.
Patterson S; Chaidos A; Neville DC; Poggi A; Butters TD; Roberts IA; Karadimitris A
J Immunol; 2008 Sep; 181(5):3268-76. PubMed ID: 18713998
[TBL] [Abstract][Full Text] [Related]
32. Antitumor impact of interferon-γ producing CD1d-restricted NKT cells in murine malignant mesothelioma.
Tagawa T; Wu L; Anraku M; Yun Z; Rey-McIntyre K; de Perrot M
J Immunother; 2013 Oct; 36(8):391-9. PubMed ID: 23994885
[TBL] [Abstract][Full Text] [Related]
33. CD1d-mediated stimulation of natural killer T cells selectively activates hepatic natural killer cells to eliminate experimentally disseminated hepatoma cells in murine liver.
Miyagi T; Takehara T; Tatsumi T; Kanto T; Suzuki T; Jinushi M; Sugimoto Y; Sasaki Y; Hori M; Hayashi N
Int J Cancer; 2003 Aug; 106(1):81-9. PubMed ID: 12794761
[TBL] [Abstract][Full Text] [Related]
34. Regulation of secondary antigen-specific CD8(+) T-cell responses by natural killer T cells.
Hong C; Lee H; Park YK; Shin J; Jung S; Kim H; Hong S; Park SH
Cancer Res; 2009 May; 69(10):4301-8. PubMed ID: 19401453
[TBL] [Abstract][Full Text] [Related]
35. CD1d-restricted NKT cells: an interstrain comparison.
Hammond KJ; Pellicci DG; Poulton LD; Naidenko OV; Scalzo AA; Baxter AG; Godfrey DI
J Immunol; 2001 Aug; 167(3):1164-73. PubMed ID: 11466330
[TBL] [Abstract][Full Text] [Related]
36. A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas.
Crowe NY; Smyth MJ; Godfrey DI
J Exp Med; 2002 Jul; 196(1):119-27. PubMed ID: 12093876
[TBL] [Abstract][Full Text] [Related]
37. CD1d is expressed on B-chronic lymphocytic leukemia cells and mediates alpha-galactosylceramide presentation to natural killer T lymphocytes.
Fais F; Morabito F; Stelitano C; Callea V; Zanardi S; Scudeletti M; Varese P; Ciccone E; Grossi CE
Int J Cancer; 2004 Apr; 109(3):402-11. PubMed ID: 14961579
[TBL] [Abstract][Full Text] [Related]
38. Activating immunity in the liver. I. Liver dendritic cells (but not hepatocytes) are potent activators of IFN-gamma release by liver NKT cells.
Trobonjaca Z; Leithäuser F; Möller P; Schirmbeck R; Reimann J
J Immunol; 2001 Aug; 167(3):1413-22. PubMed ID: 11466360
[TBL] [Abstract][Full Text] [Related]
39. Human invariant valpha24+ natural killer T cells activated by alpha-galactosylceramide (KRN7000) have cytotoxic anti-tumour activity through mechanisms distinct from T cells and natural killer cells.
Nicol A; Nieda M; Koezuka Y; Porcelli S; Suzuki K; Tadokoro K; Durrant S; Juji T
Immunology; 2000 Feb; 99(2):229-34. PubMed ID: 10692041
[TBL] [Abstract][Full Text] [Related]
40. Reversible NK1.1 surface expression on invariant liver natural killer T cells during Listeria monocytogenes infection.
Emoto M; Yoshizawa I; Emoto Y; Takahashi Y; Hurwitz R; Miamoto M; Kaufmann SH
Microbes Infect; 2007; 9(14-15):1511-20. PubMed ID: 18024119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
